Employer Health Costs Are Becoming a Shadow Payroll Tax

TL;DR: The 2026 Milliman Medical Index says a typical employer-sponsored health plan now costs $37,824 for a family of four, with average per-person costs rising 7.9%. The finance implication is blunt: employer health insurance is not just a benefits issue anymore. It is a shadow payroll line, and pharmacy plus outpatient care are deciding how much room companies have left for wages, hiring, and price discipline.

##What Milliman's 2026 Health-Cost Number Really Measures

The headline number from the 2026 Milliman Medical Index is big enough to sound unreal: $37,824 for a hypothetical family of four covered by a typical employer-sponsored plan.

That is not just the worker's paycheck deduction. It includes employer premium contributions, employee premium contributions, and out-of-pocket spending.

That distinction matters because most employees do not experience the full cost as a bill. A large piece sits inside the compensation budget, where it quietly competes with raises, headcount, bonuses, and operating margin.

#Why the full cost is easy to miss

When a worker sees a $300 or $600 payroll deduction, the benefit looks expensive but still bounded. When a CFO sees the full loaded cost of family coverage, it looks more like a second rent payment attached to every covered household.

That is the part casual readers miss. The employer health plan is one of the few household expenses that can grow inside a company budget before the household fully sees it.

##Why This Is a Payroll Story, Not Just a Healthcare Story

KFF's latest employer survey put average annual family premiums at $26,993 in 2025, with workers contributing $6,850 toward those premiums. Milliman's broader index is higher because it counts the total healthcare cost, not only premiums.

So the better business question is not, "Why are health bills high?"

It is: who absorbs the next dollar?

If employers absorb it, wage budgets get tighter. If employees absorb it, take-home pay gets weaker. If plan design absorbs it, deductibles, networks, and prior authorization become the pressure valves.

None of those choices feels like a clean price increase, but each one moves money away from somewhere else.

#The two drivers that matter most

Milliman says outpatient facility care and pharmacy services are the primary drivers of the 2026 increase, contributing 69% of the year-over-year rise. Pharmacy is the fastest-growing component, up 14.8%, with GLP-1 use and specialty drugs part of the pressure.

That combination is awkward for employers because it does not behave like a simple vendor contract.

Outpatient care is local, negotiated, and often shaped by hospital systems with real pricing power. Pharmacy is national, rebate-heavy, and increasingly tied to drugs employees may view as life-changing rather than optional.

The result is a benefits line that is hard to cut without creating workplace friction.

##Where the Cost Shows Up Inside a Company

Picture a mid-sized employer preparing open enrollment. The HR team has packets on the table, a broker on speakerphone, and three bad options on the spreadsheet.

Keep the plan rich and eat the renewal. Raise employee contributions and watch workers complain about a pay cut. Move more cost into deductibles and hope people do not blame the company when the first January claim hits.

That scene is not a healthcare policy seminar. It is operating leverage.

For many companies, the health plan sits in the same practical bucket as rent, software renewals, insurance premiums, and interest expense. It is a recurring cost that resets upward and demands a tradeoff somewhere else.

The tradeoff usually lands in one of four places:

• Lower room for wage growth, especially for hourly and middle-income workers.
• Higher employee premium contributions during open enrollment.
• Narrower networks, tighter plan design, or more utilization controls.
• More pressure to raise prices if the company has pricing power.

This is why employer health inflation belongs in a business newsletter. It changes the math of labor, not just the mood of benefits season.

##Who Has Pricing Power Now

The uncomfortable part is that employers are often treated like powerful buyers, but many are weak buyers in practice.

A large national employer can pressure vendors, carve out pharmacy programs, or experiment with centers of excellence. A smaller company usually buys through brokers and carriers, then reacts to the renewal.

Even large employers face a collective-action problem. They may dislike hospital consolidation and drug inflation, but each company mostly negotiates its own plan, protects its own recruiting pitch, and tries not to annoy its own workforce.

That gives pricing power to the parts of the system that sit closest to scarce care, specialty drugs, and local provider networks.

##What Investors and Operators Should Watch

The investor read-through is not limited to insurers.

Rising employer health costs affect retailers with large hourly workforces, manufacturers with union or near-union labor markets, hospitals negotiating commercial rates, pharmacy benefit managers, drugmakers, and software vendors selling benefits administration tools.

For operators, the risk is simpler. A benefits line that rises faster than planned can make a healthy revenue year feel worse than it should.

For employees, the risk is even more direct. A raise can be real on paper and smaller after the premium change.

The sharp point is this: employer health insurance still looks like a benefit, but financially it behaves like a private tax on payroll. Companies can redesign it, shift it, or negotiate around it. They rarely make it disappear.

##FAQ

#Why is the Milliman number higher than a normal premium figure?

Milliman counts the total cost of care for a typical employer-sponsored plan, including employer premiums, employee premiums, and out-of-pocket spending. Premium-only surveys, such as KFF's, measure a narrower slice of the same system.

#Why do pharmacy and outpatient care matter so much in 2026?

Milliman says pharmacy and outpatient facility care are driving most of the annual increase. Pharmacy is being pushed by GLP-1 utilization and specialty drugs, while outpatient care reflects site-of-care shifts, facility pricing, and provider-market structure.

#What is the business takeaway?

Employer health-cost inflation is a compensation and margin issue. The next renewal can affect wage growth, worker contributions, plan design, and pricing decisions before it ever looks like a healthcare debate.